Critical Analysis: Pliant Therapeutics (NASDAQ:PLRX) and Trevi Therapeutics (NASDAQ:TRVI) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Trevi Therapeutics, Inc. (NASDAQ:TRVI – Free Report) – Investment analysts at Leerink Partnrs issued their Q1 2024 earnings per share (EPS) estimates for shares of Trevi Therapeutics in a research note issued on Monday, February 5th. Leerink Partnrs analyst T. Smith forecasts that the company will earn ($0.09) per share for the quarter. The consensus […]
Marinus Pharmaceuticals (NASDAQ:MRNS) & Trevi Therapeutics (NASDAQ:TRVI) Financial Survey themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.